Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

PTC moves the needle to combat earlier stages of Covid-19

Most drugs being repurposed for Covid-19 focus on the more severe, later stages of the disease and preventing deaths among the worst-affected patients. However, PTC’s experimental oncology drug PTC299 has a novel, dual mechanism of action that suggests it will stop viral replication at the earlier stages of the disease, while its anti-inflammatory properties could combat the late stages of cytokine storm.

Close
Close
Close

Go Top